TOSK, INC.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.tosk.com
Clinical Trials
13
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690
- First Posted Date
- 2023-01-03
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Tosk, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05669521
- Locations
- 🇮🇳
Jawaharlal Nehru Cancer Hospital and Research Centre, Bhopal, Madhya Pradesh, India
🇮🇳Om Sai Onco Surgery Multispecialty Hospital Center, Kolhapur, Maharashtra, India
🇮🇳B. J. Medical College and Sassoon General Hospital, Pune, Maharashtra, India
Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690
- First Posted Date
- 2022-12-20
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Tosk, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05658016
- Locations
- 🇮🇳
Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu & Kashmir, India
🇮🇳Bangalore Medical college and Research Institute, Bangalore, Karnataka, India
🇮🇳Saveetha Medical College and Hospita, Chennai, Tamil Nadu, India
Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690
- First Posted Date
- 2019-08-06
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Tosk, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT04046250
- Locations
- 🇮🇳
Bangalore Cancer, Bangalore, Karnataka, India
🇮🇳Karnatak Cancer Therapy and Research Institute, Navanagar, Karnataka, India
🇮🇳Netaji Subhash Chandra Bose Cancer Hospital, Kolkata, West Bengal, India